RA Capital Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164M | Buy |
3,365,523
+2,272,727
| +208% | +$111M | 2.76% | 11 |
|
|
2025
Q1 | $23.5M | Hold |
1,092,796
| – | – | 0.39% | 37 |
|
|
2024
Q4 | $29.4M | Buy |
1,092,796
+389,716
| +55% | +$10.5M | 0.39% | 45 |
|
|
2024
Q3 | $7.56M | Buy |
+703,080
| New | +$7.56M | 0.09% | 71 |
|
|
2016
Q3 | – | Sell |
-20,540
| Closed | -$4.24M | – | 31 |
|
|
2016
Q2 | $4.24M | Sell |
20,540
-38,171
| -65% | -$7.87M | 0.59% | 26 |
|
|
2016
Q1 | $14.9M | Hold |
58,711
| – | – | 1.91% | 16 |
|
|
2015
Q4 | $20.2M | Sell |
58,711
-318
| -0.5% | -$109K | 1.99% | 19 |
|
|
2015
Q3 | $15M | Buy |
59,029
+1,962
| +3% | +$499K | 2.16% | 17 |
|
|
2015
Q2 | $16M | Buy |
+57,067
| New | +$16M | 1.61% | 19 |
|